Frontiers in Cardiovascular Medicine

NOVEMBER 19, 2024

BackgroundRestrictive cardiomyopathy (RCM) is a rare cardiomyopathy often characterized by normal or reduced ventricular chamber volume and bi-atrial enlargement, caused mainly by mutations in the myonodal gene.

Cardiomyopathy 45

Cardiomyopathy Heart Transplant Transplant Electrocardiogram 45

Journal of the American Heart Association

JANUARY 12, 2024

Journal of the American Heart Association, Ahead of Print. BackgroundPediatric dilated cardiomyopathy often leads to death or cardiac transplantation. The risk for death or cardiac transplantation up to 7 years later was lower when LVFS was improved at 1 year (hazard ratio [HR], 0.83;P=0.004) P<0.001).ConclusionsProgressive

Cardiomyopathy 40

Cardiomyopathy Pediatrics Transplant Heart Transplant 40

Circulation

NOVEMBER 11, 2024

Background:Despite the role of cardiac catheterization for hemodynamic assessment and endomyocardial biopsy (EMB) in children with cardiomyopathy, data on procedure-related major adverse events (MAE) in this population is lacking. We aim to describe the rate of MAE in children with cardiomyopathy undergoing cardiac catheterization.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Heart BMJ

NOVEMBER 27, 2023

There were great advances in the treatment of heart failure (HF) over the past decades, characterised by the inclusion of ARNI and SGLT2 inhibitors in the latest guidelines. 1 The increasing repertoire of treatments makes it even more important to select those patients who will benefit the most from these therapies.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Transplant Heart Failure 40

DAIC

APRIL 30, 2024

Heart attacks typically kill millions of cardiac muscle cells, leaving the heart in a weakened state. Since mammals cannot regenerate cardiac muscle cells on their own, heart transplants are currently the only clinically viable option for patients suffering (or likely to suffer) heart failure.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart attacks 105

The American Journal of Cardiology

DECEMBER 17, 2023

Publication date: Available online 16 December 2023 Source: The American Journal of Cardiology Author(s): Pierre Ambrosi, Alberto Riberi, Shahram Attarian, Karine Nguyen, Régis Guieu, Gilbert Habib

Heart Transplant 40

Heart Transplant Transplant Cardiomyopathy 40

Circulation: Cardiovascular Imaging

DECEMBER 18, 2023

BACKGROUND:Imaging evaluation of arrhythmogenic right ventricular cardiomyopathy (ARVC) remains challenging. LV global longitudinal strain did not add diagnostic value but was prognostic for composite end points of death, heart transplantation, or ventricular arrhythmia (log-rankP=0.04).CONCLUSIONS:In

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Cardiovascular Imaging Transplant 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:In 2018, an algorithm-based allocation system for heart transplantation (HT) was implemented in France. The cumulative incidence of waitlist mortality estimated with competing risk analysis and incidence of transplantation were compared between diagnosis groups.

Heart Failure 40

Heart Failure Congenital Heart Disease Congenital Outcomes 40

Dr. Smith's ECG Blog

JUNE 2, 2023

Overall CMR findings are consistent with arrhythmogenic cardiomyopathy. Here is a 2017 review article on ARVD in the New England Journal There is a 2010 publication by the Task Force in Diagnosis of ARVD: Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.

Tachycardia 83

Tachycardia Cardiomyopathy Electrocardiogram Article 83

DAIC

APRIL 6, 2024

This hierarchical composite approach for assessing efficacy allows diverse types of outcomes to be incorporated in ranked fashion into an overall “win ratio” reflecting the overall outcome of a drug or device.

Heart Failure 81

Heart Failure Quality of Life Outcomes Preserved Ejection Fraction 81

MIBHS

OCTOBER 31, 2024

Coronary Artery Disease (CAD) CAD, which involves the narrowing or blockage of coronary arteries due to plaque buildup, can reduce blood flow to the heart. This may result in ischemia (lack of oxygen to the heart muscle), causing parts of the heart to weaken and enlarge.

Blood Pressure 52

Blood Pressure Blood Clot Heart Valves Heart Rhythm 52

DAIC

APRIL 6, 2024

This hierarchical composite approach for assessing efficacy allows diverse types of outcomes to be incorporated in ranked fashion into an overall “win ratio” reflecting the overall outcome of a drug or device.

Heart Failure 75

Heart Failure Quality of Life Preserved Ejection Fraction Hospital 75

European Journal of Heart Failure

NOVEMBER 9, 2023

The primary composite endpoint included all-cause mortality, heart transplantation, or ventricular assist device implantation. The secondary endpoint was first heart failure admission. vs. 28.8%, p  < 0.001), more often had ischeemic cardiomyopathy (49.8% ml/min/1.73 m ml/min/1.73 m 76.5], p  < 0.001).

Outcomes 40

Outcomes Heart Failure Heart Transplant Transplant 40

Dr. Smith's ECG Blog

JANUARY 9, 2023

No family history of sudden cardiac death, cardiomyopathy, premature CAD, or other cardiac issues. Pattern consistent with Takotsubo's cardiomyopathy." He was readmitted a few weeks later for a heart failure exacerbation, diuresed, and discharged again. She died before she could get a heart transplant.

Chest Pain 52

Chest Pain Aneurysm STEMI Thrombosis 52

Cardiology Update

APRIL 9, 2024

Patients receiving semaglutide showed a greater change in Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary scores at 52 weeks than placebo. The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Myocardial Infarction 52

Myocardial Infarction Angina Aortic valve Coronary Artery Disease 52

Dr. Sanjay Gupta

MARCH 6, 2022

Other interventions that can help are devices known as left ventricular assist devices which can mechanically augment the pumping function of the heart and in the most severe cases, there is even the option of heart transplantation which whilst a huge undertaking can completely change a person’s life.

Chronic Disease 40

Chronic Disease Quality of Life Heart Failure Nursing 40

Circulation: Genomic and Precision Medicine

SEPTEMBER 6, 2023

Background:Variants in theDMDgene, that encodes the cytoskeletal protein, dystrophin, cause a severe form of dilated cardiomyopathy (DCM) associated with high rates of heart failure, heart transplantation, and ventricular arrhythmias.

Cardiomyopathy 40

Cardiomyopathy Heart Transplant Transplant Heart Failure 40

Cardiometabolic Health Congress

MARCH 8, 2024

Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52